1. Allergan's Botox still physician fave for migraine despite CGRP push — Lilly to sponsor Team USA in Tokyo Olympics — Gilead loses again in PrEP patent fight — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

plans to expand?

Discussion in 'Collegium Pharmaceutical' started by anonymous, Aug 23, 2017 at 5:43 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    any news lately?
     

  2. anonymous

    anonymous Guest

    I would guess no time soon. They did a very selective limited expansion in high growth areas and added about a dozen reps. Anything beyond that would be beyond crazy in this market.
     
  3. anonymous

    anonymous Guest

    Soon to be a contraction (layoff) based on pathetic sales trends and huge losses...
     
  4. anonymous

    anonymous Guest

    Downsizing would be a GOOD thing for the health of the company. We don't need 131 reps and we didn't need 118 before that. Could easily get by with half that. And ax the Health System whatever they're called reps. Don't need them either. While Joe's at it, he could also get rid of the Area Sales Managers. Don't need that extra layer of management of non revenue producers.
     
  5. anonymous

    anonymous Guest

    This company is hell bent on expanding because we are being lead by a big pharma exec. Nevermind the declining market they will make the mistakes of every other big pharma company that ZS consults for. They follow an old and outdated sales model in a market that should not be seeing expansion! When will these companies learn ?
     
  6. anonymous

    anonymous Guest

    bingo!
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    There is a lot of business to be had in the hospital space. It is a long process and takes time to get contracts and then pull through but in order to compete at a higher level we will need to garner that business! Hospital reps are necessary in order to take this company to the next level. I don't think a downsizing is necessary but certainly no more expansion! I'm sure ZS is still all about share of voice and reach and frequency like they have always been! They are the downfall of every good pharma company!
     
  9. KPM2

    KPM2 new user

    Joined:
    Sep 28, 2017
    Messages:
    3
    Likes Received:
    0
    Does anyone know the date of the next PDUFA date? At the last earnings call, Heffernan said Xtampza’s PDUFA date is early November for its sNDA to expand the label and include comparative data versus Oxy. I’ll be in metro D.C. at the beginnng of November and I want to attend and pick up some favorable news and comments but I haven’t been able to get anyone to confirm it is November or delayed again
     
  10. anonymous

    anonymous Guest

    OxyC, will be fully generic by then....
     
  11. anonymous

    anonymous Guest

    Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase)

    You guys are killing it!

    2 Billion in Oxy sales and you are up to 12M!

    Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase)
     
  12. anonymous

    anonymous Guest

    Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase)

    You guys are killing it!

    2 Billion in Oxy sales and you are up to 12M!

    Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase)
     
  13. anonymous

    anonymous Guest

    Just keep watching joker! This company is gaining momentum and is poised for great things! Unlike Purdue that is heading the exact opposite direction!
     
  14. anonymous

    anonymous Guest

    Investors; in ten more years we will break even and pay you 1$.
     
  15. LindaSmith

    LindaSmith new user

    Joined:
    Jan 20, 2018
    Messages:
    8
    Likes Received:
    0
    The patent to micronize a drug then imbed it in beeswax was stolen from potassium chloride tablets over 30 years ago. This company is about to get hammered.
     
  16. anonymous

    anonymous Guest

    Again, we have more than just beeswax in our patented technology. Go away
     
  17. LindaSmith

    LindaSmith new user

    Joined:
    Jan 20, 2018
    Messages:
    8
    Likes Received:
    0
    wrong, just simple micronization so anyone can copy the patent. 1987 extended release potassium chloride in beeswax. just a ripped off patent.
     
  18. anonymous

    anonymous Guest

    Your an idiot. The patent you speak of is on potassium chloride with beeswax. Our patent is on oxycodone with beeswax, carnauba wax, and fatty acids.

    Try again. Go be a b*tch somewhere else.